AdaptHealth (NASDAQ:AHCO) Director Purchases $149,930.00 in Stock

AdaptHealth Corp. (NASDAQ:AHCO) Director Kenneth Samet acquired 23,500 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The shares were acquired at an average price of $6.38 per share, with a total value of $149,930.00. Following the completion of the transaction, the director owned 48,569 shares in the company, valued at $309,870.22. The trade was a 93.74% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

AdaptHealth Stock Performance

AdaptHealth stock opened at $5.77 on Thursday. AdaptHealth Corp. has a 12-month low of $5.21 and a 12-month high of $13.43. The company has a quick ratio of 0.98, a current ratio of 1.12 and a debt-to-equity ratio of 1.37. The business’s 50-day moving average price is $9.71 and its two-hundred day moving average price is $10.45. The stock has a market cap of $784.20 million, a PE ratio of -3.37, a P/E/G ratio of 0.29 and a beta of 1.47.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AHCO. Canaccord Genuity Group set a $10.00 price target on shares of AdaptHealth in a report on Wednesday, August 5th. Robert W. Baird set a $10.00 price objective on shares of AdaptHealth in a research note on Wednesday, August 5th. UBS Group cut their target price on shares of AdaptHealth from $14.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Jefferies Financial Group raised shares of AdaptHealth from a “hold” rating to a “buy” rating and boosted their target price for the stock from $11.00 to $13.00 in a research note on Tuesday, July 21st. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of AdaptHealth in a report on Friday, May 22nd. Seven equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $10.29.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Rockefeller Capital Management L.P. boosted its position in AdaptHealth by 433.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock worth $26,000 after buying an additional 2,100 shares during the period. Assetmark Inc. increased its position in AdaptHealth by 54.8% in the 1st quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock valued at $83,000 after acquiring an additional 2,460 shares during the period. PNC Financial Services Group Inc. increased its position in AdaptHealth by 22.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock valued at $70,000 after acquiring an additional 1,279 shares during the period. Tower Research Capital LLC TRC raised its stake in shares of AdaptHealth by 318.0% during the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock valued at $90,000 after acquiring an additional 7,297 shares during the last quarter. Finally, Sanctuary Advisors LLC bought a new position in shares of AdaptHealth during the first quarter valued at $120,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.